Legal Representation
Attorney
WARREN L. ZESERMAN
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 10, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 10, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 6, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Dec 3, 2003 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 10, 2003 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 10, 2003 | I | PAPER RECEIVED | Loading... | |
| Nov 10, 2003 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 19, 2003 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 8, 2003 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 8, 2003 | I | PAPER RECEIVED | Loading... | |
| Mar 26, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 13, 2002 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 4, 2003 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Nov 20, 2002 | PETR | I | PETITION TO REVIVE-RECEIVED | Loading... |
| Jan 23, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 20, 2002 | I | PAPER RECEIVED | Loading... | |
| May 3, 2002 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 19, 2002 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 13, 2001 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 1, 2001 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Sep 26, 2001 | REIN | O | REINSTATED | Loading... |
| Jun 29, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 1, 2000 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 9, 2000 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 8, 2000 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 13, 2000 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Detailed Classifications
Class 005
Medicinal, pharmaceutical products namely those for the treatment of cardiovascular disorders, cholesterol reduction, diabetes, polysystic ovarian syndrome, nervous system diseases, retina diseases or abnormalities, kidney disease, mood disorders, and epilepsy
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005